Patent ID: 11918670
Assignee: EVONIK DR. STRAELMANS GMBH
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A  C

Claim 8:
9. The composition according to claim 1, wherein said composition comprises:
0.1% by weight to 5% by weight of monoRL-C10C12, and/or
0.1% by weight to 5% by weight of monoRL-C10C12:1,
wherein the percentages by weight refer to a sum total of all rhamnolipids present,
wherein monoRL-C10C12 is a mono-rhamnolipid of formula (I), in which one of radicals R1 and R2═(CH2)o—CH3 wherein o=6 and remaining radical R1 or R2═(CH2)o—CH3 wherein o=8,
wherein monoRL-C10C12:1 is a mono-rhamnolipid of formula (I), in which one of radicals R1 and R2═(CH2)o—CH3 where o=6 and remaining radical R1 or R2=an unbranched, unsubstituted hydrocarbon radical having 9 carbon atoms having 1 double bond,
wherein formula (I) is, wherein
m=1,
n=0.